S2Medical Investor Relations Material

Latest events

Q2 2024

23 Aug, 2024

Q1 2024

17 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from S2Medical

Access all reports
S2Medical AB is a Swedish medical technology company specializing in wound care solutions, particularly for burns and chronic wounds. The company develops, produces, and markets a range of innovative products that cover the entire wound healing process. Their portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, and the Epiprotect line, which features synthetic substitutes for allografts and xenografts, ulcer dressings, and blood-stilling membranes. Additionally, they distribute Silverlon antimicrobial dressings in the Nordic countries and operate the S2Clinic, a wound healing center in Sweden. The company is headquartered in Linköping, Sweden, and its shares are listed on the Nasdaq Stockholm.